Actively Recruiting

Age: 18Years +
FEMALE
NCT05855941

Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN)

Led by Region Västerbotten · Updated on 2024-12-16

120

Participants Needed

1

Research Sites

466 weeks

Total Duration

On this page

Sponsors

R

Region Västerbotten

Lead Sponsor

U

Umeå University

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this observational study is to learn about the added diagnostic and prognostic value of advanced medical imaging procedures in cervical cancer, endometrial cancer and ovarian cancer. The main questions it aims to answer are: * Does advanced medical imaging predict survival? * Can advanced medical imaging improve radiotherapy target planning? * Are advanced medical imaging results associated with risk markers found in tumor tissue? Participants will * Undergo four additional imaging procedures, as compared to clinical routine examinations, two at baseline and two after three months. * Be subject to clinical follow-up for five years.

CONDITIONS

Official Title

Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN)

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Previously untreated primary cervical, endometrial, or strongly suspected epithelial ovarian cancer
  • Known clinical FIGO stage
  • Older than 18 years
  • No other known current or previous malignancy within the last 10 years
Not Eligible

You will not qualify if you...

  • Imaging findings suggestive of other primary malignancy
  • Previously included suspected epithelial ovarian cancer later confirmed as other diagnosis or cancer abdominis
  • MRI incompatible devices or inability to undergo MRI

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Centre for Gynecology and Obstetrics, Umea University Hospital

Umeå, Sweden

Actively Recruiting

Loading map...

Research Team

E

Erika Figaro

CONTACT

S

Sara Strandberg, MD, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here